Ignite Creation Date:
2025-12-24 @ 10:19 PM
Ignite Modification Date:
2026-01-23 @ 2:50 PM
Study NCT ID:
NCT05409235
Status:
COMPLETED
Last Update Posted:
2024-08-09
First Post:
2022-06-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nesvategrast (OTT166) in Diabetic Retinopathy (DR)
Sponsor:
OcuTerra Therapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OTT166-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |